Furthermore, treatment of MCAO rats and OGD neurons with exosomes derived from BMSC and MSCs can target the PTEN-mediated PI3K/Akt pathway to inhibit apoptosis and increase axonal extension and myelin formation [155,156], hence proving the possibility of PTEN as a potential therapeutic target for post-stroke recovery. This evidence concerns the gene AKT1 and stroke disorder.